Figure 1. Telaglenastat + Everolimus Efficacy Outcomes.
(A) Time on study; (B) Tumor burden over time by patient; (C) Best response for target lesions; (D) Kaplan-Meier estimate of PFS.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.